K. Imamura

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

D R Spriggs, Matthew L. Sherman, H. R. Michie et al. · JNCI Journal of the National Cancer Institute · 1988 · 309 citations

Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes.

E Sariban, K. Imamura, Robert Luebbers et al. · Journal of Clinical Investigation · 1988 · 221 citations · Full text

Immunology, Pathology, Cell Death +19

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism.

Matthew L. Sherman, David R. Spriggs, K A Arthur et al. · Journal of Clinical Oncology · 1988 · 215 citations

Immunology, Pharmacotherapy, Cancer Patients +20

Potential Role for 53BP1 in DNA End-joining Repair through Direct Interaction with DNA

Kuniyoshi Iwabuchi, Balaka Piku Basu, Boris Kysela et al. · Journal of Biological Chemistry · 2003 · 152 citations · Full text

Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid

Mariko Yoshida, Takahiro Hamada, Masayuki Amagai et al. · Journal of Dermatological Science · 2005 · 149 citations

Pathogenesis, Immunology, Serologic Testing +7